Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

Related Articles by Review for PubMed (Select 21484113)

1.

Hepatic involvement by lymphoproliferative disorders post liver transplantation: PTLD.Int. Survey.

Izadi M, Fazel M, Saadat SH, Taheri S.

Hepatol Int. 2011 Sep;5(3):759-66. doi: 10.1007/s12072-011-9271-1. Epub 2011 Mar 30.

PMID:
21484113
4.
5.

Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey.

Khedmat H, Taheri S.

Exp Clin Transplant. 2011 Aug;9(4):258-64. Review.

PMID:
21819371
6.

CD20 antigen expression by lymphoproliferative disorders after kidney transplant is independently associated with a poor outcome: PTLD.Int survey.

Khedmat H, Taheri S.

Exp Clin Transplant. 2012 Aug;10(4):325-31. doi: 10.6002/ect.2011.0181. Epub 2012 Jul 3. Review.

PMID:
22758374
7.

Colorectal involvement by post-transplant lymphoproliferative disorders: a review of 81 cases.

Khedmat H, Amini M, Ghamar-Chehreh ME.

Saudi J Kidney Dis Transpl. 2014 May;25(3):597-604. Review.

8.
9.

Belatacept for kidney transplant recipients.

Masson P, Henderson L, Chapman JR, Craig JC, Webster AC.

Cochrane Database Syst Rev. 2014 Nov 24;11:CD010699. doi: 10.1002/14651858.CD010699.pub2. Review.

PMID:
25416857
10.

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.

Styczynski J, Einsele H, Gil L, Ljungman P.

Transpl Infect Dis. 2009 Oct;11(5):383-92. doi: 10.1111/j.1399-3062.2009.00411.x. Epub 2009 Jun 23. Review.

PMID:
19558376
11.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk